Investigating the Effect of Erithropoietin on Neurologic Outcome in Brain Ischemic Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013052713486N1

Enrollment

Registered

2013-10-15

Start date

2013-07-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Ischemic Patients. Vascular syndromes of brain in cerebrovascular diseases

Interventions

Intervention 1: In control group, 1cc of Normalsalin 0.9 percent is injected in 48 and 72 first hours. Intervention 2: 4000 units of Erithropoietin Subcutaneous is injected in the 48 and 72 first hou

Placebo

Treatment - Drugs

In control group, 1cc of Normalsalin 0.9 percent is injected in 48 and 72 first hours.

4000 units of Erithropoietin Subcutaneous is injected in the 48 and 72 first hours after the start of the signs

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The inclusion criterion is brain ischemic Patients between 18 to 75 years of age range who have been hospitilized in ICU wards and have GCS,9. The exclusion criterion for the present study is those outside the age range mentioned-from 18 to 75- Non-ischemic patients , poly-sythemic patients, and those having another brain-related diseases -GCS<9, malignant cancer, disordered liver function, and pregnant women.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Glasgow Coma Scale. Timepoint: before the interventoin- 7 days after the intervention-14,21, and 90 days of intervention. Method of measurement: Glasgow Coma Scale.;Glasgow Outcome Scale. Timepoint: before the interventoin- 7 days after the intervention-14,21, and 90 days of intervention. Method of measurement: Glasgow Outcome Scale.;National Institutes of Health Stroke Scale. Timepoint: before the interventoin- 7 days after the intervention-14,21, and 90 days of intervention. Method of measurement: National Institutes of Health Stroke Scale.	—

Measure

Time frame

Glasgow Coma Scale. Timepoint: before the interventoin- 7 days after the intervention-14,21, and 90 days of intervention. Method of measurement: Glasgow Coma Scale.;Glasgow Outcome Scale. Timepoint: before the interventoin- 7 days after the intervention-14,21, and 90 days of intervention. Method of measurement: Glasgow Outcome Scale.;National Institutes of Health Stroke Scale. Timepoint: before the interventoin- 7 days after the intervention-14,21, and 90 days of intervention. Method of measurement: National Institutes of Health Stroke Scale.

—

Secondary

Measure	Time frame
Duration of hospitalization. Timepoint: The last day of hospitalization. Method of measurement: Numeration of hospitalizing days.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDarabi, Ali

Kermanshah Medical Science University

darabi1354@gmail.com+98 83 1838 4185

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026